MNR experienced significant balance sheet expansion with total assets growing 61.5% while cash plummeted 59.7% and interest expense more than doubled, indicating major financing or acquisition activity.
The dramatic increase in outstanding units (from 118M to 168M) combined with massive asset growth and cash depletion suggests a major acquisition or capital raise that significantly leveraged the company. The 130% spike in interest expense confirms substantial new debt financing, while declining profitability metrics indicate the new assets aren't yet generating proportional returns.
MNR underwent major balance sheet transformation with total assets surging 61.5% to $3.8B while cash collapsed 59.7% to $42.6M, suggesting significant acquisition activity financed through debt and equity. Despite revenue growing 21.2% to $1.2B, net income declined 22.8% and operating income fell 15.8%, while interest expense more than doubled to $11.2M, indicating the new investments are diluting profitability and increasing financial leverage. The 42% increase in outstanding units combined with deteriorating cash position and rising debt costs signals investors should monitor whether management can successfully integrate and optimize these major capital deployments.
Interest expense surged 130.9% — significant debt increase or rising rates materially impacting earnings.
Inventory surged 79.1% — growing significantly faster than typical sales pace; potential demand softening or supply chain overcorrection.
Asset base grew 61.5% — expansion through organic growth, acquisitions, or capital deployment.
Cash declined 59.7% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Net income declined 22.8% — review whether driven by operations, interest costs, or non-recurring items.
Revenue growing 21.2% — solid top-line momentum, watch margins for quality of growth.
Current assets grew 17.3% — improving short-term liquidity or inventory/receivables build.
Operating profitability softening — costs rising faster than revenue, watch for margin recovery plan.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →